As. Bourinbaiar et al., THE ROLE OF CARBOXY-TERMINAL PORTION OF BETA-SUBUNIT OF HUMAN CHORIONIC-GONADOTROPIN IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Life sciences, 61(11), 1997, pp. 149-157
Citations number
49
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
Human chorionic gonadotropin (hCG) and the beta subunit of this dimer
glycoprotein hormone (beta hCG) have been reported by us to inhibit HI
V replication. In order to identify the active site responsible for th
e antiviral activity, twelve overlapping peptides spanning across beta
hCG were examined for their effect against HIV-caused cell death. Alt
hough the NH2-terminus of beta hCG appeared to contribute to activity,
the core region was biologically inert. The most potent activity was
observed with the fragment representing the carboxy-terminus of beta h
CG. The dose response curve to serial dilutions of the peptide, contai
ning amino acid residues 106-145, had a bell-shaped appearance charact
eristic of hCG and beta hCG. The peak of activity corresponded to 100
ng/ml - the dose at which two thirds of virus-exposed MT-4 T lymphocyt
es survived. None of the tested peptides were toxic to MT-4. While the
mechanism of action remains unclear, the results suggest that the COO
H-terminal portion, unique to beta hCG, confers anti-HIV activity. (C)
1997 Elsevier Science Inc.